North East and North Cumbria
ICS Formulary
 
back
6 Endocrine system
06-06-02 Bisphosphonates and other drugs affecting bone metabolism

Burosumab  Crysvita®
Formulary

  • 10mg, 20mg & 30mg solution for injection

  • Approved for treating X-linked hypophosphataemia in children and young people in accordance with NICE

Link  NICE HST 8: Burosumab for treating X-linked hypophosphataemia in children and young people

Red View adult BNF  View SPC online  View childrens BNF